Skip to main content
Log in

Serum levels of bone alkaline phosphatase in breast and prostate cancers with bone metastasis

  • Cancer
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

BALP activity in the sera of metastatic patients of breast and prostate malignancy has increased significantly. Our studies with patients in India conform the earlier reports that BALP may have a useful complementary role in the early diagnosis of bone metastases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Garnero P. and Deimas, P.D. (1993) Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J. Clin. Endocrinol. Metabolism 77, 1046–1053.

    Article  CAS  Google Scholar 

  2. Fishman, W.H. (1990) Alkaline phosphatase isozymes: recent progress (Review). Clin. Biochem. 23, 99–104.

    Article  PubMed  CAS  Google Scholar 

  3. Fedde, K.N. (1992) Human osteosarcoma cells spontaneously release matrix-vesicle-like structures with the capacity to mineralize. Bone. Miner. 17, 145–151.

    Article  PubMed  CAS  Google Scholar 

  4. Faley, J. and Bayliunk, D. (1986) Skeletal alkaline phosphatase activity as a bone formation index in vitro. Metabolism 35, 563–571.

    Article  Google Scholar 

  5. Van Straalen, J.P., Sanders, E., Prummel, M.F. and Sanders, G.T.B. (1991) Bone alkaline phosphatase as a indicator of bone formation. Clin. Chim. Acta. 201, 27–34.

    Article  PubMed  Google Scholar 

  6. Kress, B.C., Mizrahi, I.A., Armour, K.W., Mareus, R., Emkey, R.D. and Santora, A.C. (1999) Use of Bone Alkaline Phosphatase to monitor Alendronate therapy in individual postmenopausal osteoporetic women. Clin. Chem. 45, 1009–1017.

    PubMed  CAS  Google Scholar 

  7. Meijer, W.G., Van Der Veer, E. and Willemse, P.H.B. (1998) Biochemical parameters of bone metabolism in bone metastases of solid tumors (Review), Oncol. Rep. 5(1), 5–21.

    PubMed  CAS  Google Scholar 

  8. Van Hoof, V.O., Van Oosterom, A.T., Lepoutre, L.G. and de Broe, M.E. (1992) Alkaline phosphatase isoenzyme patterns in malignancy disease. Clin. Chem. 38, 2546–2551.

    PubMed  Google Scholar 

  9. Stieber, P., Nagel, D., Ritzke, C., Rossler, N., Kirsch, C.M. and Eiermann, W. (1992) Significance of bone alkaline phosphatase, CA 15-3 and CEA in the detection of bone metastases during follow up of patients suffering from breast carcinoma. Eur. J. Clin. Chem. Clin. Biochem. 30, 809–814.

    PubMed  CAS  Google Scholar 

  10. Burlina, A., Rubin, D., Secchiero, S., Sciacovelli, L., Zaninotto, M. and Plebani, M. (1994) Monitoring skeletal cancer metastases with the bone isoenzyme of tissue unspecific alkaline phosphatase. Clin. Chim. Acta 226, 151–158.

    Article  PubMed  CAS  Google Scholar 

  11. Withold, W., Schulte, U. and Reinauer, H. (1996) Method for determination of bone alkaline phosphatase activity: analytical performance and clinical usefulness in patients with metabolic and malignant bone diseases. Clin. Chem. 42, 210–217.

    PubMed  CAS  Google Scholar 

  12. Behr, W. and Bamert, J. (1986) Quantification of bone alkaline phosphatase in serum by precipitation with wheat-germ lectin: a simplified method and its clinical plausibility. Clin. Chem. 32, 1960–1966.

    PubMed  CAS  Google Scholar 

  13. Lorente, J.A., Valenzuela, H., Morote, J. and Gelabert, A. (1999) Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients. Eur. J. Nucl. Med. 26(6), 625–632.

    Article  PubMed  CAS  Google Scholar 

  14. Wolff, J.M., Ittel, T.H., Borchers, H., Boekels, O. and Jakse, G. (1999). Metastatic workup of patients with prostate cancer employing alkaline phosphatase and skeletal alkaline phosphatase. Anticancer Res. 19(4A), 2653–2655.

    PubMed  CAS  Google Scholar 

  15. Berruti, A., Dogliotti, L., Gorzegno, G., Torta, M., Tampellini, M., Tucci, M., Cerutti, S., Frezet, M.M., Stivanello, M., Sacchetto, G. and Angeli, A. (1999) Differential patterns of bone turnover in relation to bone pain and disease extent in bone cancer patients with skeletal metastases. Clin. Chem. 45(8), 1240–1247.

    PubMed  CAS  Google Scholar 

  16. Akimoto, S., Furuya, Y., Akakura, K. and Ito, H. (1998) Comparison of markers of bone formation and resorption in prostate cancer patients to predict bone metastasis. Endocr. J. 45(1), 97–104.

    Article  PubMed  CAS  Google Scholar 

  17. Diaz Martin, M.A., Traba, M.L., De la Piedra, C., Guerrero, R., Mendez Davila, C. and Garcia De La Pena, E. (1999) Aminoterminal propeptide of type I collagen and bone alkaline phosphatase in the study of bone metastases associated with prostatic carcinoma. Scand. J. Clin. Lab. Invest. 59(2), 125–132.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Girija Ramaswamy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ramaswamy, G., Rao, V.R., Krishnamoorthy, L. et al. Serum levels of bone alkaline phosphatase in breast and prostate cancers with bone metastasis. Indian J Clin Biochem 15, 110–113 (2000). https://doi.org/10.1007/BF02883737

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02883737

Keywords

Navigation